Your session is about to expire
← Back to Search
DHEA+Testosterone for Primary Ovarian Insufficiency
Study Summary
This trial will compare the effects of testosterone cream to placebo on measures of ovarian reserve, oocyte quality, embryo quality, and pregnancy rates in women with diminished ovarian reserve who have low serum testosterone and free testosterone levels after completing six weeks of DHEA supplementation.
- Primary Ovarian Insufficiency
- Female Infertility
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the typical purpose for taking a combination of DHEA and Testosterone?
"DHEA+Testosterone is often administered to patients with hypogonadotropic hypogonadism. It has been found to be a successful treatment for numerous other conditions such as 1-5 years postmenopausal symptoms, orchidectomy, and orchitis."
Is the research team still seeking participants for this experiment?
"The details on clinicaltrials.gov indicate that this trial is currently enrolling volunteers; the research project was first posted to the database on July 1st 2012 and has undergone changes as recently as November 9th 2020."
How many volunteers have been recruited to participate in this experiment?
"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, which appeared on July 1st 2012, is currently searching for participants. This research necessitates 180 patients from one centre to be enrolled."
Is there an age limit for participation in this research endeavor?
"This study is searching for individuals between 38 and 44 years old to partake in its medical trial."
Are there any precedented studies involving the combined use of DHEA and testosterone?
"At the moment, there are 29 ongoing medical trials investigating DHEA+Testosterone with 5 of those in their final stages. Of these studies, 124 are conducted at various locations across the United States including Houston, Texas."
Who is eligible to participate in this investigation?
"Candidates wanting to participate in this research must have primary ovarian insufficiency and fall between the ages of 38-44. The overall recruitment goal is 180 individuals."
Share this study with friends
Copy Link
Messenger